Treatment Protocol for COVID-19 Based on T2R Phenotype.

doi:10.3390/v13030503

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Treatment Protocol for COVID-19 Based on T2R Phenotype.

Viruses - 18 Mar 2021

Taha Mohamed A, Hall Christian A, Shortess Colin J, Rathbone Richard F, Barham Henry P

Abstract excerpt

COVID-19 has become a global pandemic of the highest priority. Multiple treatment protocols have been proposed worldwide with no definitive answer for acure. A prior retrospective study showed association between bitter taste receptor 38 (T2R38) phenotypes and the severity of COVID-19. Based on this, we proposed assessing the different T2R38 phenotypes response towards a targeted treatment protocol. Starting July...

Topics

Adult
Azithromycin
COVID-19
Clinical Protocols
Dexamethasone
Female
Humans
Male
Middle Aged
Phenotype
Prospective Studies
Receptors, G-Protein-Coupled
Retrospective Studies
SARS-CoV-2
Taste
COVID-19 Drug Treatment
Taste Receptors, Type 2

Source

Open in PubMed Open full text

Identifiers

PMID: 33803811
DOI: 10.3390/v13030503
PMCID: PMC8003114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics